Severe metabolic acidemia in infants: clinical and therapeutic aspects

Insights

Severe metabolic acidemia in infants presents with specific clinical signs. Rapid sodium bicarbonate treatment is effective and safe, but requires monitoring for hypocalcemia.

Area of Science:

  • Pediatrics
  • Neonatology
  • Critical Care Medicine

Background:

  • Severe metabolic acidemia (pH < 7) in infants can present with serious clinical signs.
  • These signs may be misdiagnosed as other conditions like pneumonia or heart failure.

Purpose of the Study:

  • To investigate the clinical manifestations of severe metabolic acidemia in infants.
  • To evaluate the efficacy and safety of sodium bicarbonate treatment.
  • To highlight the importance of accurate acid-base monitoring.

Main Methods:

  • Study included 10 infants with severe metabolic acidemia.
  • Clinical signs were observed and correlated with acidemia.
  • Treatment involved rapid intravenous sodium bicarbonate administration.
  • Monitoring for hypocalcemia was conducted.

Main Results:

  • Clinical signs such as hyperventilation, coma, vascular collapse, enlarged liver, and abdominal distension were linked to acidemia.
  • Five infants were initially misdiagnosed.
  • Rapid correction of acidemia with sodium bicarbonate led to dramatic clinical improvement.
  • Treatment was safe when hypocalcemia was managed.

Conclusions:

  • Clinical signs observed in infants are directly related to severe metabolic acidemia.
  • Sodium bicarbonate is a safe and effective treatment for severe metabolic acidemia in infants when hypocalcemia is addressed.
  • Blood bicarbonate levels alone are insufficient; repeated measurements of hydrogen ion concentration, Pco(2), and bicarbonate are crucial for accurate assessment and treatment.

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...